Rationale for T cell inhibition by cyclosporin A in major autoimmune diseases.
about
Interleukin-1β and interleukin-6 in arthritis animal models: roles in the early phase of transition from acute to chronic inflammation and relevance for human rheumatoid arthritisCRAC channel inhibition produces greater anti-inflammatory effects than glucocorticoids in CD8 cells from COPD patientsThe effect of calcineurin inhibitors in the induction and maintenance treatment of lupus nephritis: a systematic review and meta-analysis.The effect of calcineurin inhibitors in the treatment of IgA nephropathy: A systematic review and meta-analysis (PRISMA)STIM proteins: integrators of signalling pathways in development, differentiation and disease.Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling.Tetramic acid analogues produced by coculture of Saccharopolyspora erythraea with Fusarium pallidoroseum.Prolonged cyclosporine treatment of severe or recalcitrant psoriasis: descriptive study in a series of 20 patients.Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study.Anti-IL-17A blocking antibody reduces cyclosporin A-induced relapse in experimental autoimmune encephalomyelitis miceThe effect of ketoconazole on whole blood and skin ciclosporin concentrations in dogs.Estimation of tissue osteopontin levels before and after different traditional therapeutic modalities in psoriatic patients.Production of the immunosuppressant cyclosporin A by a new soil isolate, Aspergillus fumigatus, in submerged culture.
P2860
Q34274249-18B13437-0956-4976-A639-1D9EAB6277C0Q35457347-54E5CBD3-8496-4782-9261-4ABC2A89A899Q35897121-1DF21380-93DF-412E-8751-5A5DE512E571Q36119937-718A64B0-1868-4167-A3CC-27DD0D3EE6CCQ37295698-836F808B-CB7C-401F-8183-EDDC918CECA7Q37434914-71847153-9860-488C-B7C1-BC8DEC5CDF19Q37714228-A5CE3A10-2227-43B1-B9F0-BC536BCC606BQ38061479-AD51172A-354D-4E12-8867-B340A8A0794EQ38372154-BF334E0E-1346-4C07-A036-39AC6D28A0B7Q41682674-69E2A3A8-B6BF-48A3-AE84-132E5CCFE22FQ44634059-A3ECE436-950C-4C18-B577-1522D84D009BQ46029700-F5DF82C8-D326-461F-9031-1ED69DA1F3F2Q50264644-14F6E90A-58C6-490E-AB0A-FD994E7058E6
P2860
Rationale for T cell inhibition by cyclosporin A in major autoimmune diseases.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Rationale for T cell inhibition by cyclosporin A in major autoimmune diseases.
@ast
Rationale for T cell inhibition by cyclosporin A in major autoimmune diseases.
@en
type
label
Rationale for T cell inhibition by cyclosporin A in major autoimmune diseases.
@ast
Rationale for T cell inhibition by cyclosporin A in major autoimmune diseases.
@en
prefLabel
Rationale for T cell inhibition by cyclosporin A in major autoimmune diseases.
@ast
Rationale for T cell inhibition by cyclosporin A in major autoimmune diseases.
@en
P2093
P2860
P356
P1476
Rationale for T cell inhibition by cyclosporin A in major autoimmune diseases.
@en
P2093
De Santis M
Ferraccioli GF
Tomietto P
P2860
P304
P356
10.1196/ANNALS.1361.110
P407
P577
2005-06-01T00:00:00Z